Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC by Rachel Evans, Kelvin Lee, Paul K. Wallace, Mary Reid, Jason Muhitch, Askia Dozier, Circe Mesa, Patricia L. Luaces, Orestes Santos-Morales, Adrienne Groman, Carlos Cedeno, Aileen Cinquino, Daniel T. Fisher, Igor Puzanov, Mateusz Opyrchal, Christos Fountzilas, Tong Dai, Marc Ernstoff, Kristopher Attwood, Alan Hutson, Candace Johnson, Zaima Mazorra, Danay Saavedra, Kalet Leon, Agustin Lage, Tania Crombet, Grace K. Dy

Get full text

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics by Ramón A. Ortiz Carrodeguas, Geidy Lorenzo Monteagudo, Pedro P. Guerra Chaviano, Irene Álvarez Montané, Eva E. Salomón Saldívar, Leonardo Lobaina Lambert, Kirenia Camacho Sosa, Raúl Bermúdez Pino, Poncio Blanco Mustelier, Elba Valdés Rodríguez, Shairis González Piloto, Arelys Guerra de la Vega, Lizet Valdés Sánchez, Arasay Montes De Santis, Jenelly Parra Zabala, Carmen Viada González, Nadia Calvo Aguilera, Danay Saavedra Hernández, Orestes Santos Morales, Tania Crombet Ramos

Get full text

Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study by Orestes Santos-Morales, Alina Díaz-Machado, Daise Jiménez-Rodríguez, Yaisel Pomares-Iturralde, Tatiana Festary-Casanovas, Carlos A. González-Delgado, Sonia Pérez-Rodríguez, Eulalia Alfonso-Muñoz, Carmen Viada-González, Patricia Piedra-Sierra, Idrian García-García, Daniel Amaro-González, for the NeuroEPO Study Group, Julio César García-Rodríguez, Iliana Sosa-Testé, Alicia Lagarto-Parra, Laura Barrero-Viera, Marlene David-Baldo, Maura Tamayo-Rodríguez, Ivonne Rivero-Vázquez, Gricel González-Gamiz, Alis Martín-Trujillo, Yasmila Rodríguez-Fernández, Ana Alfa Ledo-de la Luz, Maylén Álvarez-Delgado, Ivón Howland-Álvarez, Yolanda Cruz-Gómez

Get full text